MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Insmed Incorporated Company Profile (NASDAQ:INSM)

Consensus Ratings for Insmed Incorporated (NASDAQ:INSM) (?)
Ratings Breakdown: 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $26.17 (138.31% upside)

Analysts' Ratings History for Insmed Incorporated (NASDAQ:INSM)
Show:
DateFirmActionRatingPrice TargetActions
4/17/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Citigroup Inc.Lower Price TargetNeutral$21.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Stifel NicolausInitiated CoverageBuy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Leerink SwannLower Price TargetOutperform$29.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Piper JaffrayReiterated RatingOverweight$41.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015HC WainwrightBoost Price TargetBuy$30.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2015Janney Montgomery ScottInitiated CoverageBuy$33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/5/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha